{"brief_title": "Study of Botulinum Toxin in Patients With Primary Hyperhidrosis", "brief_summary": "OBJECTIVES: I. Determine the optimal dose of botulinum toxin necessary to decrease sweating in patients with primary hyperhidrosis.", "detailed_description": "PROTOCOL OUTLINE: Patients receive injections of botulinum toxin in the clinical trial for 6 months. Patients undergo an iodine starch test and a sympathetic skin response test to assess the efficacy of the drug. Patients also complete questionnaires to evaluate the amount of sweating.", "condition": ["Hyperhidrosis"], "intervention_type": ["Drug"], "intervention_name": ["botulinum toxin type A"], "criteria": "- Diagnosis of hyperhidrosis - Excessive sweating in the hands, feet, armpits, forehead, or body", "gender": "All", "minimum_age": "16 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "rare disease", "mesh_term": ["Hyperhidrosis", "Botulinum Toxins, Type A", "incobotulinumtoxinA", "abobotulinumtoxinA", "onabotulinumtoxinA", "Botulinum Toxins"], "id": "NCT00004480"}